Who Owns Stryker?
Stryker is the flagship medical technology brand of Stryker Corporation (NYSE: SYK), founded in 1941 by Dr. Homer Stryker in Kalamazoo, Michigan. The brand covers orthopaedic joint implants, surgical equipment, endoscopy, hospital beds, and neurovascular devices. Stryker products are used in more than 100 million patient procedures annually.
Who Owns Stryker?
- Parent Company: Stryker Corporation
- Ownership Type: Wholly owned
- Company Type: Publicly Traded
- Stock Ticker: NYSE: SYK
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Stryker | Stryker Corporation | Wholly owned |
Where to Buy
Disclosure: We may earn commission from purchases
Stryker on AmazonHistory of Stryker
- Founded: 1941
- Founders: Dr. Homer Stryker
Dr. Homer Stryker, an orthopaedic surgeon and tinkerer, founded the Orthopaedic Frame Company in Kalamazoo, Michigan, in 1941 to manufacture his own inventions, including a turning frame for injured patients and a walking heel cast. The company was renamed Stryker Corporation in 1964, honoring its founder.
Stryker went public in 1979 under the leadership of John Brown, who became CEO in 1977 and drove the company's transformation into a diversified medical technology business through internal development and acquisition. Key milestones included the introduction of the Circ-O-Lectric hospital bed, the 1992 acquisition of Osteo (orthopaedic implants), and the 1998 Howmedica purchase from Pfizer.
The acquisition era continued under Brown and successor Kevin Lobo (CEO since 2012): MAKO Surgical (2013), Sage Products (2016), Wright Medical (2020), Vocera Communications (2022), and Inari Medical (2025, $4.9 billion, the company's largest deal). Stryker divested its U.S. spinal implants business to VB Spine in April 2025, sharpening its focus on the core orthopaedic portfolio.
The flagship Stryker brand today spans the company's core product categories and generated the bulk of its $25.1 billion FY2025 revenue, with MedSurg and Neurotechnology contributing $15.6 billion and Orthopaedics $9.5 billion.
About Stryker Corporation
Is Stryker publicly traded?
Yes. Stryker Corporation trades on the New York Stock Exchange under the ticker SYK and is an S&P 500 component.
When was Stryker founded?
Dr. Homer Stryker founded the Orthopaedic Frame Company in 1941 in Kalamazoo, Michigan. It was renamed Stryker Corporation in 1964 and went public in 1979.
Who owns Stryker?
Stryker is a public company with institutional investors holding most shares. Kevin Lobo has served as CEO since 2012.
What brands does Stryker own?
Stryker's key brands include the Stryker masterbrand, Mako SmartRobotics (surgical robots), Sage Products (patient care), and Vocera (clinical communications). Its 2025 acquisition of Inari Medical added venous thromboembolism devices.
What is Stryker's revenue?
Stryker reported net sales of $25.1 billion for fiscal year 2025, up 11.2%, with net earnings of $3.2 billion and adjusted EPS of $13.63.
- Founded: 1941
- Headquarters: Portage, Michigan, USA
- Company Type: Publicly Traded
- Stock: NYSE: SYK
- Revenue: $25.1B net sales (FY2025)
- Employees: ~56,000
Where Is Stryker Made / Based?
- Headquarters: Portage, Michigan, USA
- Manufacturing / Operations: United States, Ireland, Germany, France, China, India
Stryker Categories & Tags
Stryker Sustainability & Ethics
Stryker publishes an annual comprehensive report covering emissions, product stewardship, and its Sustainability Solutions division, which reprocesses single-use medical devices to reduce hospital waste. The company has set carbon reduction targets and reports third-party-verified data.
Stryker is regularly recognized on Fortune's Best Companies to Work For and World's Most Admired Companies lists, reflecting its internal culture and industry standing.
Stryker Recalls & Controversies
Stryker's most significant product controversy involved the 2012 voluntary recall of its Rejuvenate and ABG II modular hip stems, which led to a settlement exceeding $1 billion in 2014 and a second settlement announced in 2018 covering additional claims. The company also resolved a 2007 SEC Foreign Corrupt Practices Act matter for $16.6 million.
Like all medical device makers, Stryker manages ongoing product liability litigation and periodic FDA compliance actions, none currently material to the company's operations.
Brands Owned by Stryker Corporation
Healthcare PharmaceuticalsMako SmartRobotics
Owned by Stryker Corporation
Stryker's robotic-arm assisted surgery system for hip and knee replacement, acquired in 2013 and now the leading orthopaedic robotics platform.
surgical-roboticsorthopaedicsmedtech
Healthcare PharmaceuticalsSage Products
Owned by Stryker Corporation
Patient care and infection prevention brand owned by Stryker since 2016, maker of prepackaged bathing systems, oral care, and skin protection products.
medical-devicesinfection-preventionpatient-care
Healthcare PharmaceuticalsVocera
Owned by Stryker Corporation
Clinical communication and workflow platform owned by Stryker since 2022, providing wearable devices and software for hospital staff communication.
healthcare-itclinical-communicationswearable-tech
Stryker Ownership: Pros & Cons
Advantages
- +Top-three global orthopaedics and surgical equipment scale
- +Mako robotic platform drives implant and capital equipment lock-in
- +Consistent FY2025 growth outpacing medtech peers
- +Broad portfolio insulates from single-category downturns
- +Strong surgeon and hospital system relationships
Considerations
- -Medical device pricing pressure from hospital systems and insurers
- -Legacy hip implant litigation history
- -Regulatory recall and compliance exposure inherent to the industry
- -Integration risk from frequent large acquisitions
- -Robotics competition from Intuitive Surgical and Medtronic intensifying
Frequently Asked Questions About Stryker
Sources & Further Reading
Competitors to Stryker
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Stryker | USA | 2004 | Market leader | Global | All Genders | |
| Zimmer Biomet | USA | 2010 | Mass market | Global | All Genders | |
| Stryker | USA | 1971 | Market leader | United states | All Genders |
Learn More About Competitors
Healthcare PharmaceuticalsMako SmartRobotics
Owned by Stryker Corporation
Stryker's robotic-arm assisted surgery system for hip and knee replacement, acquired in 2013 and now the leading orthopaedic robotics platform.
surgical-roboticsorthopaedicsmedtech
Healthcare PharmaceuticalsParagon 28
Owned by Zimmer Biomet Holdings, Inc.
Medical device company focused exclusively on foot and ankle orthopedic surgery. Founded in 2010 and acquired by Zimmer Biomet in 2025 for approximately $1.1 billion.
medical-devicesorthopedicsfoot-and-ankle
Healthcare PharmaceuticalsSage Products
Owned by Stryker Corporation
Patient care and infection prevention brand owned by Stryker since 2016, maker of prepackaged bathing systems, oral care, and skin protection products.
medical-devicesinfection-preventionpatient-care
Competitive Analysis
Market Positioning: Stryker competes with 3 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Independent Alternatives to Stryker
Looking for brands with different ownership structures? These similar brands are not owned by Stryker Corporation, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsAmgen
Owned by Amgen Inc.
Master biotechnology brand of Amgen Inc., the world's largest independent biotech, covering its full portfolio of biologic medicines.
biotechnologypharmaceuticalsbiologics
Publicly Traded
Amgen operates independently without a large parent corporation.
Healthcare PharmaceuticalsNovo Nordisk
Owned by Novo Nordisk
Danish pharmaceutical company specializing in diabetes care and obesity treatment. Founded in 1923, headquartered in Bagsvaerd, Denmark. World leader in diabetes care and a leader in obesity treatment with Ozempic, Wegovy, and the investigational CagriSema. CEO Lars Fruergaard Jorgensen departed in March 2025; interim leadership under board chairman Helge Lund until a permanent CEO is appointed.
pharmaceuticalsdiabetesobesity
Publicly Traded
Novo Nordisk operates independently without a large parent corporation.
Healthcare PharmaceuticalsAlcon
Owned by Alcon Inc.
Independent publicly traded global eye care company headquartered in Geneva, Switzerland, specializing in surgical equipment, contact lenses, and ophthalmic products. Spun off from Novartis in April 2019.
eye-carecontact-lensesophthalmic
Publicly Traded
Alcon operates independently without a large parent corporation.
Healthcare PharmaceuticalsHCA Healthcare
Owned by HCA Healthcare, Inc.
HCA Healthcare is the flagship brand of the largest U.S. for-profit hospital operator, a network of 190 hospitals and about 2,500 ambulatory sites across 19 states and England.
hospitalshealthcareemergency-care
Publicly Traded
HCA Healthcare operates independently without a large parent corporation.
Healthcare PharmaceuticalsPfizer
Owned by Pfizer Inc.
American multinational pharmaceutical corporation developing and manufacturing medicines, vaccines, and consumer healthcare products, one of the world's largest pharmaceutical companies.
pharmaceuticalvaccinesmedicines
Publicly Traded
Pfizer operates independently without a large parent corporation.
Healthcare PharmaceuticalsPhilips
Owned by Koninklijke Philips N.V.
Health technology brand owned by Koninklijke Philips N.V., a publicly traded Dutch company listed on Euronext Amsterdam (PHIA). Covers medical imaging, patient monitoring, and personal health products.
healthcare-technologyelectronicsmedical-devices
Publicly Traded
Philips operates independently without a large parent corporation.
Stryker Corporation Stock Information
Jobs at Stryker Corporation
Latest News About Stryker
Related Articles About Stryker
View more articles
Brand Comparisons
Pfizer vs Johnson & Johnson: Pharma Brand Portfolios Compared
Pfizer and Johnson & Johnson are two of the most recognizable names in healthcare. But their brand portfolios look nothing alike. Here is a complete breakdown of what each company owns, how they got there, and what sets them apart.
Who Brands StaffMar 16, 2026
PharmaceuticalPfizerJohnson And Johnson
Brand Ownership
15 Pharmacy Brands and Their Corporate Parents
CVS spent $69 billion to buy Aetna. Walgreens acquired Boots for $15 billion. Amazon paid $1 billion for PillPack. Here are 15 pharmacy brands, who owns them, and how a once-diverse industry collapsed into two dominant players.
Who Brands StaffFeb 26, 2026
Pharmacy BrandsBrand OwnershipCvs
Brand Ownership
Who Owns Your Vitamins? The Hidden Corporate Parents Behind Supplement Brands
The supplement industry is worth $60+ billion but most brands are owned by pharma giants and food conglomerates. Here is who owns every major vitamin and supplement brand.
Who Brands StaffFeb 5, 2026
VitaminsSupplementsBrand Ownership
People Also Searched
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.
Brandpharmaceutical
Abbokinase
Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.
Brand in Healthcare & Pharmaceuticals
thrombolyticurokinase
Brandrsv-vaccine
Abrysvo
Pfizer's respiratory syncytial virus (RSV) vaccine approved for older adults, maternal immunization to protect infants, and younger at-risk adults. Launched 2023.
Brand in Healthcare & Pharmaceuticals
vaccinesmaternal-immunization
Branddermatology
Accutane
Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.
Brand in Healthcare & Pharmaceuticals
acne-treatmentprescription